Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation

Experimental Dermatology

Volumn 20, Issue 11, 2011, Pages 932-937

  Manca, Sonia ^a   Magrelli, Armando ^b   Cialfi, Samantha ^a   Lefort, Karine ^c   Ambra, Roberto ^d   Alimandi, Maurizio ^e   Biolcati, Gianfranco ^f   Uccelletti, Daniela ^e   Palleschi, Claudio ^e   Screpanti, Isabella ^a   Candi, Eleonora ^g   Melino, Gerry ^g   Salvatore, Marco ^b   Taruscio, Domenica ^b   Talora, Claudio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b National Centre for Rare Diseases Istituto Superiore di Sanità   (Italy)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^g UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Hailey Hailey; Notch; P63; Reactive oxygen species; Skin disease

Indexed keywords

HYDROGEN PEROXIDE; MICRORNA; MICRORNA 125B; NOTCH1 RECEPTOR; PROTEIN P63; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE SWITCHING; HAILEY HAILEY DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DNA PRIMERS; DOWN-REGULATION; HUMANS; KERATINOCYTES; MICRORNAS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PEMPHIGUS, BENIGN FAMILIAL; RECEPTOR, NOTCH1; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 80054118982     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01359.x     Document Type: Article

References (25)

1. Kellermayer R. Cell Calcium 2008: 43: 105-106.
2. Hu Z, Bonifas J M, Beech J et al. Nat Genet 2000: 24: 61-65.
3. Cialfi S, Oliviero C, Ceccarelli S et al. Br J Dermatol 2010: 162: 518-526.
4. Uccelletti D, Farina F, Pinton P et al. Mol Biol Cell 2005: 16: 4636-4647.
5. McKeon F. Genes Dev 2004: 18: 465-469.
6. Dotto G P. Oncogene 2008: 27: 5115-5123.
7. Bostjancic E, Glavac D. Acta Dermatovenerol Alp Panonica Adriat 2008: 17: 95-102.
8. Rossi M, Aqeilan R I, Neale M et al. Proc Natl Acad Sci U S A 2006: 103: 12753-12758.
9. Carroll D K, Brugge J S, Attardi L D. Cell Cycle 2007: 6: 255-261.
10. Ihrie R A, Attardi L D. Cell Cycle 2005: 4: 873-876.
11. Lena A M, Shalom-Feuerstein R, Rivetti di Val Cervo P et al. Cell Death Differ 2008: 15: 1187-1195.
12. Talora C, Cialfi S, Oliviero C et al. Blood 2006: 107: 3313-3320.
13. John B, Enright A J, Aravin A et al. PLoS Biol 2004: 2: e363.
14. Lewis B P, Burge C B, Bartel D P. Cell 2005: 120: 1521-1529.
15. Krek A, Grun D, Poy M N et al. Nat Genet 2005: 37: 495-500.
16. Xu N, Brodin P, Wei T et al. J Invest Dermatol 2011: 131: 1521-1529.
17. Sun D, Lee Y S, Malhotra A et al. Cancer Res 2011: 71: 1313-1324.
18. Shin K H, Bae S D, Hong H S et al. Biochem Biophys Res Commun 2011: 404: 896-902.
19. Landais S, Landry S, Legault P et al. Cancer Res 2007: 67: 5699-5707.
20. Candi E, Cipollone R, Rivetti di Val Cervo P et al. Cell Mol Life Sci 2008: 65: 3126-3133.
21. Talora C, Campese A F, Bellavia D et al. Biochim Biophys Acta 2008: 1782: 489-497.
22. Bowie A, O'Neill L A. Biochem Pharmacol 2000: 59: 13-23.
23. Bito T, Sumita N, Masaki T et al. Exp Dermatol 2010: 19: 654-660.
24. Kimura M, Yamamoto T, Zhang J et al. J Biol Chem 2007: 282: 33681-33690.
25. Xu S, Weerachayaphorn J, Cai S Y et al. Am J Physiol Gastrointest Liver Physiol 2010: 299: G126-G135.